Bachem stock holds steady as market cap reaches CHF 5.7 billion
Published on 08/27/2026 at 21:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Bachem Holding AG (CH0012530207) traded at CHF 75.75 on August 27, 2026, while market value stood at CHF 5.729 billion and the session range ran from CHF 75.75 to CHF 76.10. The stock was up 0.92% on the day in a snapshot updated later that afternoon.
Session range stays tight
The quoted move was small, but the setup is still useful for investors: the share price sat close to the intraday low of CHF 75.75 and only a touch below the day high of CHF 76.10. In the same snapshot, the stock also showed a beta of 0.80, pointing to lower-than-market volatility.
That kind of profile can matter when the catalyst is muted and traders are left to position around levels instead of headlines.
What the latest figures show
The most recent reported operating context visible in the search results points to the first half of 2026, which is the current reporting period for this article. Revenue and EBITDA figures for that period were not exposed in the accessible results, so the market snapshot carries the load here together with the current quote data.
For a Swiss specialty-pharma name like Bachem, that leaves attention on trading range, market value, and volatility rather than on a fresh earnings beat or miss. The current market cap of CHF 5.729 billion gives the stock a mid-to-large-cap footprint on the SIX board.
Product focus
Bachem's peptide synthesis and manufacturing platform remains the core of its business model, linking custom active ingredients to pharmaceutical development and commercial supply. The company serves drug makers that need complex peptide chemistry, which is the category investors usually watch for order flow and capacity utilization.
Price and trading view
As of August 27, 2026, the stock traded at CHF 75.75 in the SIX market snapshot, with a 52-week style reference not shown in the accessible results. The combination of a CHF 5.729 billion market cap and a 0.80 beta leaves the shares looking steadier than many biotech names.
Fact box
Company: Bachem Holding AG
ISIN: CH0012530207
Ticker: BANB
Exchange: SIX Swiss Exchange
Price (as of August 27, 2026): CHF 75.75
Market cap: CHF 5.729 billion
Sector / Industry: Health Care / Pharmaceuticals
Index membership: SPI
Social reach
Bachem stock remained within a narrow intraday band on August 27, 2026, with a market cap of CHF 5.729 billion and a beta of 0.80.
